Seems you have not registered as a member of localhost.saystem.shop!
You may have to register before you can download all our books and magazines, click the sign up button below to create a free account.
Acute Exacerbation of Chronic Hepatitis B
This book assembles recent achievements in both basic research and clinical management in the field of hepatology, virology and immunology. It provides up-to-date information for clinicians who can apply the relevant knowledge to their daily clinical practice and for researchers who are interested in clinically orientated studies. The updated and detailed technology, state-of–the-art treatment strategies provided in this book serve as references for clinicians and resident physicians in the daily management of ACLF. The rationality and strategies for basic research as well as patient management in this book can also be a valuable reference for other fatal and end stage liver diseases than HBV induced ACLF. This Volume 2 has 6 chapters and focuses on its diagnosis and management.
Women in Hepato Pancreatic Biliary (HPB) Tumors: 2021, Volume I
description not available right now.
Immunobiotics: Interactions of Beneficial Microbes with the Immune System
The term “immunobiotics” has been proposed to define microbial strains able to beneficially regulate the mucosal immune system. Research in immunobiotics has significantly evolved as researchers employed cutting-edge technologies to investigate the complex interactions of these beneficial microorganisms with the immune system. During the last decade, our understanding of immunobiotics-host interaction was profoundly transformed by the discovery of microbial molecules and host receptors involved in the modulation of gut associated immune system, as well as the systemic and distant mucosal immune systems. In recent years, there has been a substantial increase in the number of reports descr...
Reducing the Harm of Medication - Recent Trends in Pharmacovigilance
description not available right now.
Polysaccharides
Key Features: Details the source, production, structures, properties, and current and potential applications of polysaccharides. Discusses general strategies of isolation, separation and characterization of polysaccharides. Describes botanical, algal, animal, and microbial sources of polysaccharides. Demonstrates the importance of carbohydrates in new lead generation. Highlights the range of possibilities for polysaccharides to make real-world impact.
Molecular Medical Microbiology
Molecular Medical Microbiology, Third Edition presents the latest release in what is considered to be the first book to synthesize new developments in both molecular and clinical research. The molecular age has brought about dramatic changes in medical microbiology, along with great leaps in our understanding of the mechanisms of infectious disease. This third edition is completely updated, reviewed and expanded, providing a timely and helpful update for microbiologists, students and clinicians in the era of increasing use of molecular techniques, changing epidemiology and prevalence, and increasing resistance of many pathogenic bacteria. Written by experts in the field, chapters include cut...
Diagnosis And Treatment Of Covid-19 With Integrated Chinese And Western Medicine
This handbook mainly introduces the diagnosis and treatment methods of COVID-19 in traditional Chinese and Western medicine. In particular, principles for clinical treatments, therapeutic methods and prognostic rehabilitation interventions for the four types of clinical manifestations are elaborated. A chapter detailing guidance for healthy individuals on scientific prevention measures is also included, making this book suitable for not only frontline COVID-19 personnel and TCM enthusiasts, but also the general public.
Wuhan
"Dali L. Yang's Fateful Choices offers a penetrating study of China's management of the COVID-19 outbreak in Wuhan, a momentous event that has reverberated globally as the severe pandemic in a century. Yang's work sheds light on the advantage Chinese health decision-makers had, including access to the novel coronavirus's genomic sequences from several laboratories, as early as the end of December 2019. It was at this time that an emergency action program was initiated to combat the burgeoning outbreak in Wuhan"--
